Centre Henri Becquerel
Clinical trials sponsored by Centre Henri Becquerel, explained in plain language.
-
Blood test aims to catch Lymphoma's return sooner after CAR-T treatment
Disease control OngoingThis study is testing if a blood test can quickly detect tiny amounts of leftover cancer after patients receive CAR-T cell therapy for a type of lymphoma that has come back or not responded to other treatments. The goal is to see if getting these test results within three weeks c…
Phase: NA • Sponsor: Centre Henri Becquerel • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New DNA test aims to spot hidden cancer after surgery
Diagnosis OngoingThis study is testing a new method to check if any cancer cells are left behind after surgery for oral cancer. Researchers will look for tiny traces of cancer DNA in the area where the tumor was removed. The goal is to develop a more sensitive tool than current methods to help gu…
Phase: NA • Sponsor: Centre Henri Becquerel • Aim: Diagnosis
Last updated Mar 27, 2026 12:38 UTC
-
Could a simple blood test track a rare cancer?
Knowledge-focused OngoingThis study is testing whether a new type of blood test can be used to monitor a rare and aggressive form of blood cancer called peripheral T-cell lymphoma. Researchers will analyze DNA from tumors that circulates in the blood of 45 patients who are newly diagnosed or whose cancer…
Sponsor: Centre Henri Becquerel • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC
-
Blood test could replace scans for predicting Lymphoma's return
Knowledge-focused OngoingThis study is testing a new blood test, called a 'liquid biopsy,' to see if it can better predict whether lymphoma will come back after initial treatment. It will compare the blood test results to the standard PET-CT scan in 108 patients with B-cell or Hodgkin lymphoma. The goal …
Phase: NA • Sponsor: Centre Henri Becquerel • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:15 UTC